Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel ...

Researchers at MUSC Hollings Cancer Center have identified a signaling loop involved in the growth and persistence of leukemia cells—and developed a novel immunotherapy that can disrupt that loop to ...